Try our beta test site
1 study found for:    20925993 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab
Condition: Crohn's Disease
Interventions: Biological: Certolizumab pegol;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.